Seasonal Flu Vaccination Enhanced Service – Decision-Making Framework for Practices

Introduction

We recognise that some GP practices are considering opting out of the Seasonal Flu Vaccination Enhanced Service. Historically, this has been uncommon; however, given the significant challenges currently facing practices, it is an important moment to provide clear guidance. While it is essential to deliver high-quality patient care, practices must carefully assess their financial viability and sustainability. This guidance is designed to support practices in making informed decisions, emphasising the importance of evaluating the overall financial impact of participation.

Key Considerations for Practices

1. Discretionary Nature of the Service
   • Participation in the Seasonal Flu Vaccination Enhanced Service is voluntary and renewed annually. Practices are not contractually obliged to continue providing this service in subsequent years.
2. Patient Expectations
   • If your practice has historically participated, patients may expect flu vaccinations to continue being available through your services. Clear communication will be essential should you decide to discontinue participation.
3. Financial Viability 
   • Practices should focus on a detailed analysis of the financial impact, considering both the revenue generated (top-line) and the overall profit after costs (bottom-line). Given static reimbursement rates for some time, ensure your evaluation accounts for inflation and other rising costs.
4. Collaborative Service Delivery 
   • Community pharmacists are now delivering vaccinations under the same Enhanced Service, intended to provide patients with broader access. However, data suggests this has not significantly increased overall vaccine uptake. Consider how this affects your local population and your practice’s role.

Contractual and Regulatory Responsibilities

If a practice decides to opt out, the following points should be noted:

• Duty of Co-operation (Clause 11A of GMS Regulations)
  • Practices must reasonably cooperate with relevant stakeholders (e.g., NHS England, local authorities, and integrated care boards) to:
    • Understand vaccine uptake and barriers.
    • Assist in strategy development to improve vaccination rates, where applicable.
• Information Sharing
  • If requested, practices may need to provide relevant data (e.g., patient eligibility, housebound status, contraindications) to other service providers. However, this does not extend to performing activities beyond the scope of reasonable cooperation.

Communication with the Integrated Care Board (ICB)

• Should your practice choose to step back from the Enhanced Service, it is advisable to inform the ICB, providing a rationale for your decision. This helps maintain transparency and aids the ICB in planning alternative arrangements.

Next Steps

For practices uncertain about their course of action:

• Conduct a detailed financial review of the programme.
• Engage with your Local Medical Committee medical director for tailored advice.
• Inform the ICB of your considerations and seek their perspective on support and delivery options.

Your LMC remains available to assist with queries, including interpreting regulatory obligations or facilitating communication with stakeholders.

For further assistance, contact the LMC office or reach out directly to your regional medical director.

Note: This guidance is informational and does not constitute legal or financial advice.

see also:  Surrey & Sussex LMCs: Seasonal Flu Guide 2024/25

About this page

Updated on Friday 7 March 2025

504 views